168 related articles for article (PubMed ID: 37751612)
1. HPV vaccination for prevention of head and neck cancer among men.
El Hussein MT; Dhaliwal S
Nurse Pract; 2023 Oct; 48(10):25-32. PubMed ID: 37751612
[TBL] [Abstract][Full Text] [Related]
2. Landscape assessment for gender neutral human papillomavirus vaccination recommendations including head and neck cancer burden data.
Morais E; El Mouaddin N; Schuurman S; De A
Vaccine; 2021 Sep; 39(39):5461-5473. PubMed ID: 34452775
[TBL] [Abstract][Full Text] [Related]
3. Human Papilloma Virus- Associated Head and Neck Cancer: A 21st Century Pandemic; Assessing Student Awareness and Knowledge.
Kavanagh FG; McNamara AT; Fopohunda O; Keogh IJ
Ir Med J; 2018 Dec; 111(10):837. PubMed ID: 30558733
[TBL] [Abstract][Full Text] [Related]
4. Awareness of Human Papillomavirus (HPV) and HPV Vaccination amongst the General Population in Germany: Lack of Awareness and Need for Action.
Sharma SJ; Schartinger VH; Wuerdemann N; Langer C; Möllenhoff K; Collin L; Sutton L; Riedl D; Kreuter A; Lechner M; Wieland U; Klussmann JP
Oncol Res Treat; 2022; 45(10):561-567. PubMed ID: 35850111
[TBL] [Abstract][Full Text] [Related]
5. Practices regarding human Papillomavirus counseling and vaccination in head and neck cancer: a Canadian physician questionnaire.
Anderson S; Isaac A; Jeffery CC; Robinson JL; Isaac DM; Korownyk C; Biron VL; Seikaly H
J Otolaryngol Head Neck Surg; 2017 Oct; 46(1):61. PubMed ID: 29073940
[TBL] [Abstract][Full Text] [Related]
6. Medical students' knowledge about human papillomavirus (HPV), HPV vaccine and head and neck cancer.
Solis-Torres N; Braverman-Diaz I; Rivera-Morales LA; Perez-Sanchez JJ; Perez-Bravo VS; Neris-Sanchez AJ; Vera A; Diaz-Algorri Y
Hum Vaccin Immunother; 2024 Dec; 20(1):2344248. PubMed ID: 38659106
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma.
Gillison ML; Chaturvedi AK; Anderson WF; Fakhry C
J Clin Oncol; 2015 Oct; 33(29):3235-42. PubMed ID: 26351338
[TBL] [Abstract][Full Text] [Related]
8. Medical students' knowledge of HPV, HPV vaccine, and HPV-associated head and neck cancer.
Du EY; Adjei Boakye E; Taylor DB; Kuziez D; Rohde RL; Pannu JS; Simpson MC; Patterson RH; Varvares MA; Osazuwa-Peters N
Hum Vaccin Immunother; 2022 Nov; 18(6):2109892. PubMed ID: 36070503
[TBL] [Abstract][Full Text] [Related]
9. Trends in Human Papillomavirus-Associated Cancers, Demographic Characteristics, and Vaccinations in the US, 2001-2017.
Liao CI; Francoeur AA; Kapp DS; Caesar MAP; Huh WK; Chan JK
JAMA Netw Open; 2022 Mar; 5(3):e222530. PubMed ID: 35294540
[TBL] [Abstract][Full Text] [Related]
10. A Current Update on Human Papillomavirus-Associated Head and Neck Cancers.
Tumban E
Viruses; 2019 Oct; 11(10):. PubMed ID: 31600915
[TBL] [Abstract][Full Text] [Related]
11. [Infection of human papillomavirus and head and neck cancer].
Song C; Zhang SK; Qiao YL
Zhonghua Zhong Liu Za Zhi; 2023 Jan; 45(1):39-43. PubMed ID: 36709118
[TBL] [Abstract][Full Text] [Related]
12. Dynamics of oral human papillomavirus infection in healthy population and head and neck cancer.
Vani NV; Madhanagopal R; Swaminathan R; Ganesan TS
Cancer Med; 2023 May; 12(10):11731-11745. PubMed ID: 36846921
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic human papilloma virus vaccination in head and neck: indications and future perspectives.
Wierzbicka M; Berkhof JH; Dikkers FG
Curr Opin Otolaryngol Head Neck Surg; 2019 Apr; 27(2):85-90. PubMed ID: 30694913
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of head and neck cancer.
Rettig EM; D'Souza G
Surg Oncol Clin N Am; 2015 Jul; 24(3):379-96. PubMed ID: 25979389
[TBL] [Abstract][Full Text] [Related]
15. Analysis of human leukocyte antigen associations in human papillomavirus-positive and -negative head and neck cancer: Comparison with cervical cancer.
Ekanayake Weeramange C; Shu D; Tang KD; Batra J; Ladwa R; Kenny L; Vasani S; Frazer IH; Dolcetti R; Ellis JJ; Sturm RA; Leo P; Punyadeera C
Cancer; 2022 May; 128(10):1937-1947. PubMed ID: 35176174
[TBL] [Abstract][Full Text] [Related]
16. HPV vaccination in head and neck HPV-related pathologies.
Wierzbicka M; Józefiak A; Jackowska J; Szydłowski J; Goździcka-Józefiak A
Otolaryngol Pol; 2014; 68(4):157-73. PubMed ID: 24981297
[TBL] [Abstract][Full Text] [Related]
17. Examining the incidence of human papillomavirus-associated head and neck cancers by race and ethnicity in the U.S., 1995-2005.
Cole L; Polfus L; Peters ES
PLoS One; 2012; 7(3):e32657. PubMed ID: 22448226
[TBL] [Abstract][Full Text] [Related]
18. Could the human papillomavirus vaccination be cost-effective in males for the prevention of oropharyngeal cancer?
Isaranuwatchai W; Graham DM; Siu LL; Hoch JS
Expert Rev Pharmacoecon Outcomes Res; 2014 Dec; 14(6):763-5. PubMed ID: 25095728
[TBL] [Abstract][Full Text] [Related]
19. Estimating the clinical benefits of vaccinating boys and girls against HPV-related diseases in Europe.
Marty R; Roze S; Bresse X; Largeron N; Smith-Palmer J
BMC Cancer; 2013 Jan; 13():10. PubMed ID: 23298365
[TBL] [Abstract][Full Text] [Related]
20. Efficacy, effectiveness and safety of vaccination against human papillomavirus in males: a systematic review.
Harder T; Wichmann O; Klug SJ; van der Sande MAB; Wiese-Posselt M
BMC Med; 2018 Jul; 16(1):110. PubMed ID: 30016957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
